Published in Cancer Weekly, November 11th, 2008
"These multiple poster presentations at ENA underscore the therapeutic promise of both obatoclax and GMX1777," said Glenn J. Gormley, M.D., Ph.D., President and Chief Executive Officer of Gemin X. "These data provide Gemin X with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.